~40 spots leftby Jan 2026

Evaluating Voiding Trial Volume for Urinary Retention

Palo Alto (17 mi)
Overseen byDavid Lovejoy, MD
Age: 18+
Sex: Female
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Wake Forest University Health Sciences
No Placebo Group

Trial Summary

What is the purpose of this trial?This trial tests if patients can urinate on their own after surgery to catch and treat urinary problems early. It aims to prevent complications like bladder damage and infections, improving patient comfort and satisfaction.

Eligibility Criteria

This trial is for nonpregnant women over 18 who are having surgery for pelvic organ prolapse or urinary incontinence. It's not open to those with preoperative voiding issues requiring self-catheterization, recurrent UTIs, bladder injuries during surgery, intolerance to at least 150cc backfill, neuromuscular disorders, or pregnancy.

Treatment Details

The study is looking at the best volume of fluid to use when testing if patients can urinate properly after urogynecologic surgery. Women will be randomly placed into a control group or a test group to determine this optimal volume.
2Treatment groups
Experimental Treatment
Active Control
Group I: control group (voids 2/3 of the volume backfilled)Experimental Treatment1 Intervention
control group
Group II: test group (voids ½ of the total volume backfilled)Active Control1 Intervention
test group)

Find a clinic near you

Research locations nearbySelect from list below to view details:
Wake Forest University Health SciencesWinston-Salem, NC
Loading ...

Who is running the clinical trial?

Wake Forest University Health SciencesLead Sponsor

References